Melanin-like nanoparticles as a potential novel therapeutic approach in ADPKD

In this issue of EMBO Molecular Medicine, Sun and colleagues report the development of a novel therapeutic approach, and preclinical proof-of-concept evidence of its efficacy, for Autosomal Dominant Polycystic Kidney Disease (ADPKD) (Sun et al, 2024). L. Cassina and A. Boletta discuss the study by Sun et al, in this issue of EMBO Mol Med, that describes a new therapeutic approach based on melanin-like nanoparticles for Autosomal Dominant Polycystic Kidney Disease.